Drug Type Small molecule drug |
Synonyms 5-hydroxy-L-tryptophan, 5-hydroxytryptophan L-form, L-5-HTP + [5] |
Target |
Mechanism 5-HT receptor agonists(Serotonin (5-HT) receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date TW (31 Dec 1995), |
Regulation- |
Molecular FormulaC11H12N2O3 |
InChIKeyLDCYZAJDBXYCGN-VIFPVBQESA-N |
CAS Registry4350-09-8 |
Start Date28 Sep 2023 |
Sponsor / Collaborator |
Start Date01 Jun 2022 |
Sponsor / Collaborator |
Start Date01 Mar 2021 |
Sponsor / Collaborator |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D07339 | Oxitriptan |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Phenylketonurias | TW | 31 Dec 1995 | |
Depressive Disorder | CH | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Suicidal Ideation | Phase 1 | US | 20 Apr 2023 |
Study | Phase | Population | Analyzed Enrollment | Group | Results | Evaluation | Publication Date |
---|
Phase 2 | 166 | luqxnjqvul(omxalyzjnv) = peilnhvvgk rdnosouaph (dqdeeewxoe, 1.97; 4.03) View more | Negative | 05 Aug 2022 | |||
Phase 4 | 15 | gdlgrdiesy(ycblrighwp) = nkqkujxekh qfhncuphxr (uzubrtmesr, jeshdiutwm - gbbngkucsv) View more | - | 04 Jan 2018 |